|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online October 27, 2005
doi: 10.1242/10.1242/jcs.02628
Research Article |

Institut für Biochemie, Universitätsklinikum RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany
Author for correspondence (e-mail: mueller-newen{at}rwth-aachen.de)
Accepted 9 August 2005
The cytokine receptor gp130 is the shared signalling subunit of the IL-6-type cytokines. Interleukin-6 (IL-6) signals through gp130 homodimers whereas leukaemia inhibitory factor (LIF) exerts its action through a heterodimer of gp130 and the LIF receptor (LIFR). Related haematopoietic receptors such as the erythropoietin receptor have been described as preformed dimers in the plasma membrane. Here we investigated gp130 homodimerization and heterodimerization with the LIFR by fluorescence resonance energy transfer (FRET) and bimolecular fluorescence complementation (BiFC). We detected a FRET signal between YFP- and CFP-tagged gp130 at the plasma membrane of unstimulated cells that does not increase upon IL-6 stimulation. However, FRET between YFP-tagged gp130 and CFP-tagged LIFR considerably increased upon LIF stimulation. Using a BiFC approach that detects stable interactions we show that fluorescence complementation of gp130 constructs tagged with matching `halves' of fluorescent proteins increases upon IL-6 stimulation. Taken together, these findings suggest that transient gp130 homodimers on the plasma membrane are stabilized by IL-6 whereas heterodimerization of gp130 with the LIFR is mainly triggered by the ligand. This view is supported by the observation that the simultaneous action of two IL-6 binding domains on two gp130 molecules is required to efficiently recruit a fluorescent IL-6 (YFP-IL-6) to the plasma membrane.
Key words: Cytokine receptor, Gp130, LIFR, Dimerization, FRET, BiFC
This article has been cited by other articles:
![]() |
R.-H. Tao and I. N. Maruyama All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells J. Cell Sci., October 1, 2008; 121(19): 3207 - 3217. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kawahara, H. Ueda, K. Tsumoto, I. Kumagai, and T. Nagamune Mimicry of Erythropoietin and Interleukin-6 Signalling by an Antibody/Cytokine Receptor Chimera in Murine Myeloid 32D Cells J. Biochem., April 1, 2007; 141(4): 563 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Cole, H. W. McLaughlin, and D. I. Johnson Use of Bimolecular Fluorescence Complementation To Study In Vivo Interactions between Cdc42p and Rdi1p of Saccharomyces cerevisiae Eukaryot. Cell, March 1, 2007; 6(3): 378 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Metz, M. Wiesinger, M. Vogt, H. Lauks, G. Schmalzing, P. C. Heinrich, and G. Muller-Newen Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP: FUSED RECEPTOR DOMAINS ACT AS HIGH AFFINITY CYTOKINE-BINDING PROTEINS J. Biol. Chem., January 12, 2007; 282(2): 1238 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stuhlmann-Laeisz, S. Lang, A. Chalaris, P. Krzysztof, S. Enge, J. Eichler, U. Klingmuller, M. Samuel, M. Ernst, S. Rose-John, et al. Forced Dimerization of gp130 Leads to Constitutive STAT3 Activation, Cytokine-independent Growth, and Blockade of Differentiation of Embryonic Stem Cells Mol. Biol. Cell, July 1, 2006; 17(7): 2986 - 2995. [Abstract] [Full Text] [PDF] |
||||